Your search returned 6 results.

Results
	1.	Heparin-induced thrombocytopenia (HIT). A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004. [electronic resource] by Magnani, Harry N Gallus, Alex Producer: 20060921 In: Thrombosis and haemostasis vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Treatment of 51 pregnancies with danaparoid because of heparin intolerance. [electronic resource] by Lindhoff-Last, Edelgard Kreutzenbeck, Hans-Joachim Magnani, Harry N Producer: 20050705 In: Thrombosis and haemostasis vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Safety and efficacy of danaparoid (Orgaran) use in children. [electronic resource] by Bidlingmaier, Christoph Magnani, Harry N Girisch, Monika Kurnik, Karin Producer: 20060413 In: Acta haematologica vol. 115 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Identification of the abnormal cholestatic lipoprotein (LP-X) in familial lecithin:Cholesterol acyltransferase deficiency. [electronic resource] by Torsvik, Harald Berg, Kåre Magnani, Harry N McConathy, Walter J Alaupovic, Peter Gjone, Egil Publication details: FEBS letters Aug 1972 In: FEBS letters vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	The pharmacokinetics of fondaparinux sodium in healthy volunteers. [electronic resource] by Donat, François Duret, Jean Pierre Santoni, Alix Cariou, Roger Necciari, José Magnani, Harry de Greef, Rik Producer: 20021118 In: Clinical pharmacokinetics vol. 41 Suppl 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s. [electronic resource] by Lubenow, Norbert Warkentin, Theodore E Greinacher, Andreas Wessel, Antje Sloane, Debi-Ann Krahn, Erica L Magnani, Harry N Producer: 20060919 In: Thrombosis research vol. 117 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)